Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2007;93:200-204; doi:10.1136/hrt.2006.093799
Copyright © 2007 BMJ Publishing Group Ltd & British Cardiovascular Society

CARDIAC IMAGING AND NON-INVASIVE TESTING

A pretest prognostic score to assess patients undergoing exercise or pharmacological stress testing

Anthony Morise, Matthew Evans, Farrukh Jalisi, Rajendra Shetty, Marc Stauffer

Section of Cardiology, Department of Medicine, West Virginia University School of Medicine, Morgantown, West Virginia, USA

Correspondence to:
Correspondence to:
Dr Anthony Morise
Section of Cardiology, HSC-South, WVU, Morgantown, WV 26506, USA;amorise{at}pol.net

ABSTRACT

Objective: A previously developed pretest score was validated to stratify patients presenting for exercise testing with suspected coronary disease according to the presence of angiographic coronary disease. Our goal was to determine how well this pretest score risk stratified patients undergoing pharmacological and exercise stress tests concerning prognostic endpoints.

Design: Retrospective cohort analysis.

Setting: University hospital stress laboratory.

Patients: 7452 unselected ambulatory patients with symptoms of suspected coronary disease undergoing stress testing between 1995 and 2004.

Main outcomes measures: All-cause death, cardiac death and non-fatal myocardial infarction.

Results: The rate of all-cause death was 5.5% (CI 5.0 to 6.1) with 4.3 (SD 2.4) years of follow-up (Exercise 2.8% (CI 2.3 to 3.2) v Pharmacological group 11.9% (CI 10.5 to 13.3); p<0.001). The rate of cardiac death/myocardial infarction was 2.6% (CI 2.2 to 3.0) (Exercise 1.4% (CI 1.1 to 1.8) v Pharmacological group 5.3% (CI 4.3 to 6.2); p<0.001). In both groups, stratification by pretest score was significant for all-cause death and the combined endpoint. However, stratification was more effective in the pharmacological group using the combined endpoint rather than all-cause death. Pharmacological stress patients in intermediate and high risk groups were at higher risk than their respective exercise test cohorts. Referral for pharmacological stress testing was found to be an independent predictor of time to death (2.7 (CI 2.0 to 3.6); p<0.001).

Conclusion: A pretest score previously validated to stratify according to angiographic outcomes, effectively risk stratified pharmacological and exercise stress patients according to the combined endpoint of cardiac death/myocardial infarction.

Keywords: coronary disease; pharmacological stress; prognosis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.